TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kintor Pharmaceutical Ltd ( (HK:9939) ) has shared an announcement.
Kintor Pharmaceutical Limited has entered into a brand and sales operation cooperation agreement with Hangzhou ToMax Co., Ltd. to enhance the overseas market presence of its cosmetic products. This strategic partnership aims to leverage Kintor’s expertise in research, development, and manufacturing with ToMax’s marketing and promotional capabilities, thereby expanding the reach and sales of Kintor’s cosmetics globally. The collaboration is expected to result in mutual benefits and a win-win outcome for both parties, strengthening Kintor’s position in the cosmetics industry.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited, incorporated in the Cayman Islands, operates in the pharmaceutical industry with a focus on developing and commercializing innovative therapies. The company is expanding its market presence by venturing into the cosmetics sector, offering products such as anti-hair loss, acne treatment, and skin whitening solutions.
YTD Price Performance: 18.56%
Average Trading Volume: 1,269,324
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$506.3M
For an in-depth examination of 9939 stock, go to TipRanks’ Stock Analysis page.